Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05490927 · ClinicalTrials.gov registry record · NA
Ethnic Microaggressions and Smoking Behaviors Among Latinx Adults
A NA study of Smoking and Discrimination, Racial, sponsored by University of Houston.
- Recruiting
- Registry status
- NA
- Development phase
- 90
- Enrollment target
- 1
- Study location
NCT05490927: Recruiting NA study of Smoking and Discrimination, Racial, sponsored by University of Houston.
NCT05490927 is a NA study of Smoking and Discrimination, Racial that is actively recruiting participants, run by University of Houston. The registered enrollment target is 90 participants, below the 454-participant average among 123 other Smoking trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05490927, a NA study of Smoking and Discrimination, Racial, is actively recruiting participants, sponsored by University of Houston.
- RECRUITING
- Registry status
- NA
- Development phase
- 90 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to examine whether microaggressions relate to multimodal facets of smoking behavior, subjective withdrawal, and urge/craving. Additionally, the second aim is to examine whether smoking deprivation moderates the relation between microaggressions and multiple facets of smoking behavior, subjective withdrawal, and urge/craving.
Primary Outcome
Smoking behaviors will be operationally defined as smoking topography (e.g., puff behavior) measured via the Clinical Research Support System (CReSS; Plowshare Technologies, Borgwaldt KC, Inc., Virginia).
Conditions Studied
Interventions
- BEHAVIORAL Microaggression Recall and Relapse Analogue Task
Study Locations (1)
Texas
- RESTORE Laboratory: Research on Emotion, Substance Treatment Outcomes, and Racial Equity - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2022-10-13 |
| Est. Completion | 2025-07-31 |
| Phase | NA |
What NCT05490927 shows while recruiting
NCT05490927 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 90 participants, a relatively small participant target, below the 454-participant average among 123 other Smoking trials with a reported enrollment target (80% lower).
The record links to 2 conditions, with Smoking appearing as the primary indexed condition, and to 1 intervention - of which Microaggression Recall and Relapse Analogue Task is the first listed.
NCT05490927 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT05490927 about?
NCT05490927 is a clinical study titled "Ethnic Microaggressions and Smoking Behaviors Among Latinx Adults". The purpose of this study is to examine whether microaggressions relate to multimodal facets of smoking behavior, subjective withdrawal, and urge/craving. Additionally, the second aim is to examine whether smoking deprivation moderates the relation between microaggressions and multiple facets of smo...
What is the current status of trial NCT05490927?
This trial is currently recruiting. It is a NA study. The enrollment target is 90 participants. The study started on 2022-10-13. Estimated completion is 2025-07-31.
What conditions does trial NCT05490927 study?
This clinical trial studies the following conditions: Smoking, Discrimination, Racial.
What interventions are being tested in trial NCT05490927?
The interventions under investigation include: Microaggression Recall and Relapse Analogue Task (BEHAVIORAL).
Who is sponsoring clinical trial NCT05490927?
This trial is sponsored by University of Houston, which has 64 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05490927 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Smoking
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05490927's enrollment target sits among peer trials
90 80th of 123 higher than 43 of 123 other Smoking trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Smoking trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Clinical Alternatives for Reducing Harm Using E-cigarettes
RECRUITING · NA
-
Black Impact: The Mechanisms Underlying Psychosocial Stress Reduction in a Cardiovascular Health Intervention
RECRUITING · NA
-
Refer2Quit: Evaluating a Proactive, Tailored, Population Health Approach for Tobacco Treatment for Household Smokers Through a Pediatric Care Network
RECRUITING · NA
-
Enhancing Motivation to Quit Smoking Via Self-Help Intervention Targeted to Cancer Type
RECRUITING · NA
-
Personalized Tobacco Treatment in Primary Care (MOTIVATE)
RECRUITING · NA
-
Take A Break - Rural
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02521311 · 90 participants · Phase 2
Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)
- NCT02939573 · 90 participants · Phase 2
A Randomized Multicenter Study for Isolated Skin Vasculitis
- NCT03128879 · 90 participants · Phase 2
Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL
- NCT03184038 · 90 participants · NA
Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI